130 related articles for article (PubMed ID: 16874484)
1. Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.
Lavergne V; Laverdière M; Duchesne A; Béliveau C; Delorme J; Di Zazzo A; Labbé AC
Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):532-4. PubMed ID: 16874484
[No Abstract] [Full Text] [Related]
2. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
Schoening TE; Wagner J; Arvand M
Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
[TBL] [Abstract][Full Text] [Related]
3. Emerging erythromycin resistance among group B streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Yoon KJ; Song W
Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):52-4. PubMed ID: 11245325
[TBL] [Abstract][Full Text] [Related]
4. [Streptococcus agalactiae increase in resistance to erythromycin and clindamycin in vaginal-anal colonization in third quarter of pregnancy in one decade of universal screening].
Abarzúa F; Arias A; García P; Ralph C; Cerda J; Riedel I; Gárate C
Rev Chilena Infectol; 2011 Aug; 28(4):334-7. PubMed ID: 22052397
[TBL] [Abstract][Full Text] [Related]
5. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Sánchez BA; Agreda MC; Picazo JJ
Antimicrob Agents Chemother; 2003 Mar; 47(3):1112-4. PubMed ID: 12604549
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal spread of Streptococcus agalactiae resistant to clindamycin among pregnant women in Brazil.
Barros RR; de Souza AF; Luiz FB
J Antimicrob Chemother; 2016 Jul; 71(7):2054-6. PubMed ID: 27029847
[No Abstract] [Full Text] [Related]
7. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.
Hsueh PR; Teng LJ; Lee LN; Ho SW; Yang PC; Luh KT
Antimicrob Agents Chemother; 2001 Nov; 45(11):3205-8. PubMed ID: 11600380
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Zimbabwean Streptococcus agalactiae (group B Streptococcus; GBS) isolates to four different antibiotics.
Moyo SR; Maeland JA; Munemo ES
Cent Afr J Med; 2001; 47(9-10):226-9. PubMed ID: 12808772
[TBL] [Abstract][Full Text] [Related]
9. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.
Back EE; O'Grady EJ; Back JD
Antimicrob Agents Chemother; 2012 Feb; 56(2):739-42. PubMed ID: 22143529
[TBL] [Abstract][Full Text] [Related]
10. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus.
DiPersio LP; DiPersio JR
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):79-82. PubMed ID: 16368478
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel keyhole phenotype in double-disk diffusion assays of clindamycin-resistant erythromycin-sensitive strains of Streptococcus agalactiae.
Srinivasan U; Miller B; Debusscher J; Marrs CF; Zhang L; Seo YS; Oh KY; Kim MY; Yoon HR; Kl M; Foxman B
Microb Drug Resist; 2011 Mar; 17(1):121-4. PubMed ID: 21166574
[TBL] [Abstract][Full Text] [Related]
12. Characterization and mechanisms of resistance of group B streptococcal isolates obtained at a community hospital.
Varman M; Romero JR; Cornish NE; Manley J; Meza JL; Zach TL; Chartrand SA
Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):431-3. PubMed ID: 15926062
[No Abstract] [Full Text] [Related]
13. The outpatient institutional antibiogram does not accurately reflect the susceptibility of prepartum group B streptococcal isolates to erythromycin and clindamycin.
Gray KL; Fulcher LC; McElmeel ML; Xenakis EM; Jorgensen JH
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):457-9. PubMed ID: 21982562
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
Pinheiro S; Radhouani H; Coelho C; Gonçalves A; Carvalho E; Carvalho JA; Ruiz-Larrea F; Torres C; Igrejas G; Poeta P
Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.
Gygax SE; Schuyler JA; Kimmel LE; Trama JP; Mordechai E; Adelson ME
Antimicrob Agents Chemother; 2006 May; 50(5):1875-7. PubMed ID: 16641466
[TBL] [Abstract][Full Text] [Related]
16. Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students.
Manning SD; Pearlman MD; Tallman P; Pierson CL; Foxman B
Clin Infect Dis; 2001 Dec; 33(12):E137-9. PubMed ID: 11698992
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.
Desjardins M; Delgaty KL; Ramotar K; Seetaram C; Toye B
J Clin Microbiol; 2004 Dec; 42(12):5620-3. PubMed ID: 15583291
[TBL] [Abstract][Full Text] [Related]
18. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.
Heelan JS; Hasenbein ME; McAdam AJ
J Clin Microbiol; 2004 Mar; 42(3):1263-4. PubMed ID: 15004089
[TBL] [Abstract][Full Text] [Related]
19. Erythromycin or Clindamycin - is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?
Leszczyński P; Sokół-Leszczyńska B; Pietrzak B; Sawicka-Grzelak A; Wielgoś M
Pol J Microbiol; 2017 Jul; 66(2):265-268. PubMed ID: 28735311
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.
Wang H; Zhao C; He W; Zhang F; Zhang L; Cao B; Sun Z; Xu Y; Yang Q; Mei Y; Hu B; Chu Y; Liao K; Yu Y; Hu Z; Ni Y
Antimicrob Agents Chemother; 2013 Mar; 57(3):1538-41. PubMed ID: 23295933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
